Literature DB >> 23104173

Trastuzumab and chemotherapy may be appropriate for small, node-negative, HER2-positive breast cancer.

Patrick G Morris, Heather L McArthur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23104173      PMCID： PMC3481903          DOI： 10.1634/theoncologist.2012-0318

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  2 in total

1.  Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer.

Authors:  Heather L McArthur; Kathleen M Mahoney; Patrick G Morris; Sujata Patil; Lindsay M Jacks; Jane Howard; Larry Norton; Clifford A Hudis
Journal:  Cancer       Date:  2011-06-16       Impact factor: 6.860

2.  Trastuzumab for small HER-2+ breast cancer: small tumor, big decision.

Authors:  Roisin M Connolly; Aditya Bardia
Journal:  Oncologist       Date:  2012-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.